Literature DB >> 26342994

The MAGE protein family and cancer.

Jenny L Weon1, Patrick Ryan Potts2.   

Abstract

The Melanoma Antigen Gene (MAGE) protein family is a large, highly conserved group of proteins that share a common MAGE homology domain. Intriguingly, many MAGE proteins are restricted in expression to reproductive tissues, but are aberrantly expressed in a wide variety of cancer types. Originally discovered as antigens on tumor cells and developed as cancer immunotherapy targets, recent literature suggests a more prominent role for MAGEs in driving tumorigenesis. This review will highlight recent developments into the function of MAGEs as oncogenes, their mechanisms of action in regulation of ubiquitin ligases, and outstanding questions in the field.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26342994      PMCID: PMC4688208          DOI: 10.1016/j.ceb.2015.08.002

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  80 in total

1.  A RING finger protein Praja1 regulates Dlx5-dependent transcription through its ubiquitin ligase activity for the Dlx/Msx-interacting MAGE/Necdin family protein, Dlxin-1.

Authors:  Aya Sasaki; Yoshiko Masuda; Kazuhiro Iwai; Kyoji Ikeda; Ken Watanabe
Journal:  J Biol Chem       Date:  2002-04-16       Impact factor: 5.157

2.  Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer.

Authors:  José Baselga; Mario Campone; Martine Piccart; Howard A Burris; Hope S Rugo; Tarek Sahmoud; Shinzaburo Noguchi; Michael Gnant; Kathleen I Pritchard; Fabienne Lebrun; J Thaddeus Beck; Yoshinori Ito; Denise Yardley; Ines Deleu; Alejandra Perez; Thomas Bachelot; Luc Vittori; Zhiying Xu; Pabak Mukhopadhyay; David Lebwohl; Gabriel N Hortobagyi
Journal:  N Engl J Med       Date:  2011-12-07       Impact factor: 91.245

Review 3.  Early signaling pathways activated by c-Kit in hematopoietic cells.

Authors:  D Linnekin
Journal:  Int J Biochem Cell Biol       Date:  1999-10       Impact factor: 5.085

4.  Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response.

Authors:  Olga Aprelikova; Silvia Pandolfi; Sean Tackett; Mark Ferreira; Konstantin Salnikow; Yvona Ward; John I Risinger; J Carl Barrett; John Niederhuber
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

5.  Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy.

Authors:  Richard A Morgan; Nachimuthu Chinnasamy; Daniel Abate-Daga; Alena Gros; Paul F Robbins; Zhili Zheng; Mark E Dudley; Steven A Feldman; James C Yang; Richard M Sherry; Giao Q Phan; Marybeth S Hughes; Udai S Kammula; Akemi D Miller; Crystal J Hessman; Ashley A Stewart; Nicholas P Restifo; Martha M Quezado; Meghna Alimchandani; Avi Z Rosenberg; Avindra Nath; Tongguang Wang; Bibiana Bielekova; Simone C Wuest; Nirmala Akula; Francis J McMahon; Susanne Wilde; Barbara Mosetter; Dolores J Schendel; Carolyn M Laurencot; Steven A Rosenberg
Journal:  J Immunother       Date:  2013-02       Impact factor: 4.456

6.  Expression of MAGE-C1/CT7 and MAGE-C2/CT10 predicts lymph node metastasis in melanoma patients.

Authors:  Alessandra Curioni-Fontecedro; Natko Nuber; Daniela Mihic-Probst; Burkhardt Seifert; Davide Soldini; Reinhard Dummer; Alexander Knuth; Maries van den Broek; Holger Moch
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

7.  MAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis.

Authors:  Fan Yang; Xingchun Zhou; Xia Miao; Tao Zhang; Xiaojun Hang; Ru Tie; Nan Liu; Fei Tian; Fuli Wang; Jianlin Yuan
Journal:  Breast Cancer Res Treat       Date:  2014-04-01       Impact factor: 4.872

8.  High expression of MAGE-A9 correlates with unfavorable survival in hepatocellular carcinoma.

Authors:  Xuefeng Gu; Maoying Fu; Zhijun Ge; Feng Zhan; Yuqin Ding; Huihui Ni; Wei Zhang; Yanfang Zhu; Xiaojun Tang; Lin Xiong; Jiang Li; Liang Qiu; Yuan Mao; Jin Zhu
Journal:  Sci Rep       Date:  2014-10-15       Impact factor: 4.379

Review 9.  Molecular Pathways: Is AMPK a Friend or a Foe in Cancer?

Authors:  D Grahame Hardie
Journal:  Clin Cancer Res       Date:  2015-07-07       Impact factor: 12.531

10.  Regulation of WASH-dependent actin polymerization and protein trafficking by ubiquitination.

Authors:  Yi-Heng Hao; Jennifer M Doyle; Saumya Ramanathan; Timothy S Gomez; Da Jia; Ming Xu; Zhijian J Chen; Daniel D Billadeau; Michael K Rosen; Patrick Ryan Potts
Journal:  Cell       Date:  2013-02-28       Impact factor: 41.582

View more
  69 in total

1.  Loci-specific differences in blood DNA methylation in HBV-negative populations at risk for hepatocellular carcinoma development.

Authors:  Katarzyna Lubecka; Kirsty Flower; Megan Beetch; Jay Qiu; Lucinda Kurzava; Hannah Buvala; Adam Ruhayel; Samer Gawrieh; Suthat Liangpunsakul; Tracy Gonzalez; George McCabe; Naga Chalasani; James M Flanagan; Barbara Stefanska
Journal:  Epigenetics       Date:  2018-07-30       Impact factor: 4.528

2.  Cancer cells activate damage-tolerant and error-prone DNA synthesis.

Authors:  Elizabeth Mutter-Rottmayer; Yanzhe Gao; Cyrus Vaziri
Journal:  Mol Cell Oncol       Date:  2016-09-19

Review 3.  Cellular and disease functions of the Prader-Willi Syndrome gene MAGEL2.

Authors:  Klementina Fon Tacer; Patrick Ryan Potts
Journal:  Biochem J       Date:  2017-06-16       Impact factor: 3.857

4.  Evolution of Melanoma Antigen-A11 (MAGEA11) During Primate Phylogeny.

Authors:  Christopher S Willett; Elizabeth M Wilson
Journal:  J Mol Evol       Date:  2018-03-24       Impact factor: 2.395

5.  The cancer/testis antigen MAGEC2 promotes amoeboid invasion of tumor cells by enhancing STAT3 signaling.

Authors:  X Song; J Hao; J Wang; C Guo; Y Wang; Q He; H Tang; X Qin; Y Li; Y Zhang; Y Yin
Journal:  Oncogene       Date:  2016-10-24       Impact factor: 9.867

6.  Investigation into the expression levels of MAGEA6 in esophageal squamous cell carcinoma and esophageal adenocarcinoma tissues.

Authors:  Jun Hao; Shuying Li; Jintao Li; Zhu Jiang; Maliha Ghaffar; Minglian Wang; Runqing Jia; Su Chen; Yangjunqi Wang; Yi Zeng
Journal:  Exp Ther Med       Date:  2019-07-05       Impact factor: 2.447

7.  Delayed endometrial decidualisation in polycystic ovary syndrome; the role of AR-MAGEA11.

Authors:  Kinza Younas; Marcos Quintela; Samantha Thomas; Jetzabel Garcia-Parra; Lauren Blake; Helen Whiteland; Adnan Bunkheila; Lewis W Francis; Lavinia Margarit; Deyarina Gonzalez; R Steven Conlan
Journal:  J Mol Med (Berl)       Date:  2019-06-29       Impact factor: 4.599

8.  MAGEA1 interacts with FBXW7 and regulates ubiquitin ligase-mediated turnover of NICD1 in breast and ovarian cancer cells.

Authors:  J Zhao; Y Wang; C Mu; Y Xu; J Sang
Journal:  Oncogene       Date:  2017-05-01       Impact factor: 9.867

Review 9.  Emerging roles of the MAGE protein family in stress response pathways.

Authors:  Rebecca R Florke Gee; Helen Chen; Anna K Lee; Christina A Daly; Benjamin A Wilander; Klementina Fon Tacer; Patrick Ryan Potts
Journal:  J Biol Chem       Date:  2020-09-13       Impact factor: 5.157

Review 10.  Emerging Contributions of Cancer/Testis Antigens to Neoplastic Behaviors.

Authors:  Zane A Gibbs; Angelique W Whitehurst
Journal:  Trends Cancer       Date:  2018-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.